5Misiti S, Schomburg L, Yen PM, et al.Expression and hormonal regulation of coactivator and corepressor genes [J]. Endocrinology, 1998, 139: 2 493.
6Fisher B, Costantino JP, Wickerham DL, et al.Tamoxifen for prevention of breast cancer:NASBP P-1 Study[J].J Natl Cancer Inst,1998,90(18):1 371.
7Fisher B, Diagnam J, Bryant J, et al.Five versus more than five years of tamoxifen therapy for breast cancer patients with negtive lymph nodes and estrogen receptor-positive tumors[J] .J Natl Cancer Inst, 1996, 88:1529.
8Love RR, Mazess rb, Barden HS, et al .Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer[J] .N Eng J Med, 1992,326:852.
9Saarto T,Blomqvist C,Ehnholm C,et al.Antiatherogenic effects of adjuvant antiestrogens:a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer[J] .J Clin Oncol, 1996, 14:429.
10Coombes RC, Haynes BP, Dowsett M, et al. Idoxifene:report of a phase I study in patients with metastatic breast cancer[J] . Cancer Res, 1995, 55:1 070.
